TREATMENT OF LEAKY OR DAMAGED TIGHT JUNCTIONS AND ENHANCING EXTRACELLULAR MATRIX
    1.
    发明申请
    TREATMENT OF LEAKY OR DAMAGED TIGHT JUNCTIONS AND ENHANCING EXTRACELLULAR MATRIX 有权
    泄漏或损伤的轻微结节的治疗和增强细胞外基质

    公开(公告)号:US20080274979A1

    公开(公告)日:2008-11-06

    申请号:US12049190

    申请日:2008-03-14

    IPC分类号: A61K38/10 A61K38/02 A61P7/00

    摘要: Self assembling peptides and peptidomimetics can be utilized for the treatment and support of disorders associated with leaky or damaged tight junction and weak, diseased, or injured extracellular matrix. The self-assembling materials generally have alternating hydrophilic or hydrophobic residues or hydrophobic and/or hydrophilic sections which allow the material to react or interact with the glycoproteins found in the ECM. Diseases in which treatment with these materials applied to or near the site in need of treatment include diabetic retinopathy, sepsis, burns, and certain neurodegenerative diseases such as Parkinson's and Alzheimer's. The formulations can be administered by injection, spraying, topically or by catheter or via a wound dressing or other material to which it is applied and then applied to the site in need of treatment.

    摘要翻译: 自组装肽和肽模拟物可用于治疗和支持与渗漏或损伤的紧密连接和弱的,患病的或受损的细胞外基质相关的疾病。 自组装材料通常具有交替的亲水或疏水残基或疏水和/或亲水部分,其允许材料与ECM中发现的糖蛋白反应或相互作用。 应用于需要治疗的部位或附近的这些材料的治疗的疾病包括糖尿病性视网膜病变,败血症,烧伤和某些神经变性疾病如帕金森病和阿尔茨海默病。 制剂可以通过注射,喷雾,局部地或通过导管或通过其施用的伤口敷料或其它材料来施用,然后施用于需要治疗的部位。

    Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
    2.
    发明授权
    Treatment of leaky or damaged tight junctions and enhancing extracellular matrix 有权
    治疗渗漏或损伤的紧密连接并增强细胞外基质

    公开(公告)号:US09415084B2

    公开(公告)日:2016-08-16

    申请号:US12049190

    申请日:2008-03-14

    摘要: Self assembling peptides and peptidomimetics can be utilized for the treatment and support of disorders associated with leaky or damaged tight junction and weak, diseased, or injured extracellular matrix. The self-assembling materials generally have alternating hydrophilic or hydrophobic residues or hydrophobic and/or hydrophilic sections which allow the material to react or interact with the glycoproteins found in the ECM. Diseases in which treatment with these materials applied to or near the site in need of treatment include diabetic retinopathy, sepsis, burns, and certain neurodegenerative diseases such as Parkinson's and Alzheimer's. The formulations can be administered by injection, spraying, topically or by catheter or via a wound dressing or other material to which it is applied and then applied to the site in need of treatment.

    摘要翻译: 自组装肽和肽模拟物可用于治疗和支持与渗漏或损伤的紧密连接和弱的,患病的或受损的细胞外基质相关的疾病。 自组装材料通常具有交替的亲水或疏水残基或疏水和/或亲水部分,其允许材料与ECM中发现的糖蛋白反应或相互作用。 应用于需要治疗的部位或附近的这些材料的治疗的疾病包括糖尿病性视网膜病变,败血症,烧伤和某些神经变性疾病如帕金森病和阿尔茨海默病。 制剂可以通过注射,喷雾,局部地或通过导管或通过其施用的伤口敷料或其它材料来施用,然后施用于需要治疗的部位。